Drug General Information
Drug ID
D02AFZ
Former ID
DNC014322
Drug Name
2-Propyl-beta-carboline-2-ium iodide
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530824]
Structure
Download
2D MOL

3D MOL

Formula
C14H15IN2
Canonical SMILES
CCC[N+]1=CC2=C(C=C1)C3=CC=CC=C3N2.[I-]
InChI
1S/C14H14N2.HI/c1-2-8-16-9-7-12-11-5-3-4-6-13(11)15-14(12)10-16;/h3-7,9-10H,2,8H2,1H3;1H
InChIKey
MUASLNFMPGFPJA-UHFFFAOYSA-N
PubChem Compound ID
Target and Pathway
Target(s) Cholinesterase Target Info Inhibitor [530824]
Acetylcholinesterase Target Info Inhibitor [530824]
KEGG Pathway Glycerophospholipid metabolism
Cholinergic synapse
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathwayP00042:Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
Pathway Interaction Database ATF-2 transcription factor network
PathWhiz Pathway Phospholipid Biosynthesis
WikiPathways Irinotecan PathwayWP727:Monoamine Transport
Biogenic Amine Synthesis
Acetylcholine Synthesis
Integrated Pancreatic Cancer Pathway
References
Ref 530824J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.
Ref 530824J Med Chem. 2010 May 13;53(9):3611-7.Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.